IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Iterum Therapeutics PLC

CUSIP: G6333L200 | 66 institutional holders

Quarters

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q2 2026

Barclays PLC10,795
0.0% of portfolio›$539
Cypress Capital Management LLC (WY)66
0.0% of portfolio›$3
StyleTurnoverLocationFiled
Barclays PLC
10,795$5390.0%CoreMediumLondon, United Kingdom2026-08-14
Cypress Capital Management LLC (WY)
66$30.0%CoreLowSheridan, WY2026-08-06